These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8195886

  • 21. ECG-triggered 18F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox.
    Poussier S, Maskali F, Tran N, Person C, Maureira P, Boutley H, Karcher G, Lacolley P, Régnault V, Fay R, Marie PY.
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1745-50. PubMed ID: 20393712
    [Abstract] [Full Text] [Related]

  • 22. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
    Schneider CA, Voth E, Theissen P, Wienhard K, Wagner R, Baer FM, Sechtem U, Schicha H.
    Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
    [Abstract] [Full Text] [Related]

  • 23. Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping.
    Bax JJ, Visser FC, Raymakers PG, Van Lingen A, Cornel JH, Huitink JM, Elhendy A, Heine RJ, Visser CA.
    Nucl Med Commun; 1997 Mar; 18(3):200-6. PubMed ID: 9106773
    [Abstract] [Full Text] [Related]

  • 24. Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients. Role of free fatty acid and insulin levels.
    Monti LD, Lucignani G, Landoni C, Moresco RM, Piatti P, Stefani I, Pozza G, Fazio F.
    Diabetes; 1995 May; 44(5):537-42. PubMed ID: 7729612
    [Abstract] [Full Text] [Related]

  • 25. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Taylor M, Wallhaus TR, Degrado TR, Russell DC, Stanko P, Nickles RJ, Stone CK.
    J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Influence of high and low plasma insulin levels on the uptake of fluorine-18 fluorodeoxyglucose in myocardium and femoral muscle, assessed by planar imaging.
    Huitink JM, Visser FC, van Leeuwen GR, van Lingen A, Bax JJ, Heine RJ, Teule GJ, Visser CA.
    Eur J Nucl Med; 1995 Oct; 22(10):1141-8. PubMed ID: 8542898
    [Abstract] [Full Text] [Related]

  • 29. The comparison of 2-18F-2-deoxyglucose and 15-(ortho-123I-phenyl)-pentadecanoic acid uptake in persisting defects on thallium-201 tomography in myocardial infarction.
    Henrich MM, Vester E, von der Lohe E, Herzog H, Simon H, Kuikka JT, Feinendegen LE.
    J Nucl Med; 1991 Jul; 32(7):1353-7. PubMed ID: 2066789
    [Abstract] [Full Text] [Related]

  • 30. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose.
    Bøtker HE, Böttcher M, Schmitz O, Gee A, Hansen SB, Cold GE, Nielsen TT, Gjedde A.
    J Nucl Cardiol; 1997 Jul; 4(2 Pt 1):125-32. PubMed ID: 9115064
    [Abstract] [Full Text] [Related]

  • 31. [Myocardial blood flow and glucose metabolism in patients with myocardial infarction evaluated by positron emission tomography: comparison with left ventriculography].
    Fudo T, Kambara H, Hashimoto T, Hayashi M, Kawai C, Senda M, Tamaki N, Yonekura Y.
    J Cardiol; 1988 Mar; 18(1):13-20. PubMed ID: 3265437
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Usefulness of 18F-fluorodeoxyglucose positron emission tomography for evaluating myocardial viability in old myocardial infarction].
    Niwayama H, Yoshida K, Masuda Y, Inagaki Y.
    Kaku Igaku; 1992 Nov; 29(11):1341-52. PubMed ID: 1484426
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia.
    Marshall RC, Tillisch JH, Phelps ME, Huang SC, Carson R, Henze E, Schelbert HR.
    Circulation; 1983 Apr; 67(4):766-78. PubMed ID: 6600659
    [Abstract] [Full Text] [Related]

  • 36. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose.
    Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Schelbert HR, Nienaber CA, Phelps ME.
    J Nucl Med; 1989 Mar; 30(3):359-66. PubMed ID: 2786939
    [Abstract] [Full Text] [Related]

  • 37. Plasma adiponectin is modestly decreased during 24-hour insulin infusion but not after inhibition of lipolysis by Acipimox.
    Dullaart RP, Riemens SC, Meinardi JR, Wolffenbuttel BH, Sluiter WJ.
    Scand J Clin Lab Invest; 2005 Mar; 65(6):523-31. PubMed ID: 16179286
    [Abstract] [Full Text] [Related]

  • 38. Re-evaluation of myocardial FDG uptake in hyperglycemia.
    Kubota K, Kubota R, Yamada S, Tada M, Takahashi T, Iwata R.
    J Nucl Med; 1996 Oct; 37(10):1713-7. PubMed ID: 8862317
    [Abstract] [Full Text] [Related]

  • 39. Simplified PET quantitation of myocardial glucose utilization.
    Nakagawa K, Namba H, Iyo M, Fukushi K, Irie T, Yamanouchi M, Shikama N, Himi T, Yoshida K, Masuda Y.
    J Nucl Med; 1995 Nov; 36(11):2094-102. PubMed ID: 7472605
    [Abstract] [Full Text] [Related]

  • 40. Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET.
    Herrero P, Sharp TL, Dence C, Haraden BM, Gropler RJ.
    J Nucl Med; 2002 Nov; 43(11):1530-41. PubMed ID: 12411556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.